Parallel evolution of fluconazole resistance and tolerance in Candida glabrata
Frontiers in Cellular and Infection Microbiology · 27.09.2024 · 14
DOI: 10.3389/fcimb.2024.1456907 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 27.09.2024. Verfasst von Lijun Zheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Candida glabrata, Fluconazole, Drug Resistance, Fungal, Antifungal Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
With the growing population of immunocompromised individuals, opportunistic fungal pathogens pose a global health threat. Candida species, particularly C. albicans and non-albicans Candida species such as C. glabrata , are the most prevalent pathogenic fungi. Azoles, especially fluconazole, are widely used therapeutic options.
Objective
This study investigates how C. glabrata adapts to fluconazole, with a focus on understanding the factors regulating fluconazole tolerance and its relationship to resistance.
Methods
This study compared the factors regulating fluconazole tolerance between C. albicans and C. glabrata . We analyzed the impact of temperature on fluconazole tolerance, and requirement of calcineurin and Hsp90 for maintenance of fluconazole tolerance. We isolated colonies from edge, inside and outside of inhibition zone in disk diffusion assays. And we exposed C. glabrata strain to high concentrations of fluconazole and investigated the mutants for development of fluconazole resistance and tolerance.
Results
We found temperature modulated tolerance in the opposite way in C. albicans strain YJB-T1891 and C. glabrata strain CG4. Calcineurin and Hsp90 were required for maintenance of fluconazole tolerance in both species. Colonies from inside and outside of inhibition zones did not exhibited mutated phenotype, but colonies isolated from edge of inhibition zone exhibited diverse phenotype changes. Moreover, we discovered that high concentrations (16-128 μg/mL) of fluconazole induce the simultaneous but parallel development of tolerance and resistance in C. glabrata , unlike the sole development of tolerance in C. albicans .
Conclusion
This study highlights that while tolerance to fluconazole is a common response in Candida species, the specific molecular mechanisms and evolutionary pathways that lead to this response vary between species. Our findings emphasize the importance of understanding the regulation of fluconazole tolerance in different Candida species to develop effective therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Pharmacy, The 960th Hospital of PLA, Jinan, China.
- Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Zitieren
APA
Zheng, L., Xu, Y., Wang, C., Dong, Y., & Guo, L. (2024). Parallel evolution of fluconazole resistance and tolerance in Candida glabrata. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1456907
Vancouver
Zheng L, Xu Y, Wang C, Dong Y, Guo L. Parallel evolution of fluconazole resistance and tolerance in Candida glabrata. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1456907
BibTeX
@article{Zheng2024,
author = {Zheng, Lijun and Xu, Yi and Wang, Chen and Dong, Yubo and Guo, Liangsheng},
title = {Parallel evolution of fluconazole resistance and tolerance in Candida glabrata},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
volume = {14},
doi = {10.3389/fcimb.2024.1456907}
}
EUVIMED